These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 20840834
1. TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague. Lin JS, Park S, Adamovicz JJ, Hill J, Bliska JB, Cote CK, Perlin DS, Amemiya K, Smiley ST. Vaccine; 2010 Dec 16; 29(2):357-62. PubMed ID: 20840834 [Abstract] [Full Text] [Related]
2. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague. Arnaboldi PM, Sambir M, D'Arco C, Peters LA, Seegers JF, Mayer L, McCormick AA, Dattwyler RJ. Vaccine; 2016 Nov 11; 34(47):5768-5776. PubMed ID: 27745954 [Abstract] [Full Text] [Related]
3. Antibodies and cytokines independently protect against pneumonic plague. Kummer LW, Szaba FM, Parent MA, Adamovicz JJ, Hill J, Johnson LL, Smiley ST. Vaccine; 2008 Dec 09; 26(52):6901-7. PubMed ID: 18926869 [Abstract] [Full Text] [Related]
4. A Recombinant Attenuated Yersinia pseudotuberculosis Vaccine Delivering a Y. pestis YopENt138-LcrV Fusion Elicits Broad Protection against Plague and Yersiniosis in Mice. Singh AK, Curtiss R, Sun W. Infect Immun; 2019 Oct 09; 87(10):. PubMed ID: 31331960 [Abstract] [Full Text] [Related]
5. Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague. Do Y, Koh H, Park CG, Dudziak D, Seo P, Mehandru S, Choi JH, Cheong C, Park S, Perlin DS, Powell BS, Steinman RM. Eur J Immunol; 2010 Oct 09; 40(10):2791-6. PubMed ID: 20812236 [Abstract] [Full Text] [Related]
6. Delivery of Yersinia pestis antigens via Escherichia coli outer membrane vesicles offered improved protection against plague. Tong Z, Zhang X, Guo X, Wu G, Cao S, Zhang Y, Meng X, Wang T, Wang Y, Song Y, Yang R, Du Z. mSphere; 2024 Sep 25; 9(9):e0033024. PubMed ID: 39158304 [Abstract] [Full Text] [Related]
10. Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge. Branger CG, Sun W, Torres-Escobar A, Perry R, Roland KL, Fetherston J, Curtiss R. Vaccine; 2010 Dec 16; 29(2):274-82. PubMed ID: 20979987 [Abstract] [Full Text] [Related]
11. Yersinia pestis caf1 variants and the limits of plague vaccine protection. Quenee LE, Cornelius CA, Ciletti NA, Elli D, Schneewind O. Infect Immun; 2008 May 16; 76(5):2025-36. PubMed ID: 18347051 [Abstract] [Full Text] [Related]
13. LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague. Sun W, Sanapala S, Henderson JC, Sam S, Olinzock J, Trent MS, Curtiss R. Infect Immun; 2014 Oct 16; 82(10):4390-404. PubMed ID: 25114109 [Abstract] [Full Text] [Related]
17. Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients. Li B, Du C, Zhou L, Bi Y, Wang X, Wen L, Guo Z, Song Z, Yang R. Clin Vaccine Immunol; 2012 Feb 16; 19(2):228-34. PubMed ID: 22190397 [Abstract] [Full Text] [Related]
20. Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity. Miller NC, Quenee LE, Elli D, Ciletti NA, Schneewind O. Infect Immun; 2012 Apr 16; 80(4):1572-82. PubMed ID: 22252870 [Abstract] [Full Text] [Related] Page: [Next] [New Search]